Contribution of neurogenic mechanisms to the pathogenesis of chronic joint pain

Contribution of neurogenic mechanisms to the pathogenesis of chronic joint pain

Objective: to study the contribution of neurogenic mechanisms to the pathogenesis of chronic pain in patients with rheumatoid arthritis (RA), knee osteoarthritis (OAk) and ankylosing spondylitis (AS). To evaluate the effectiveness of an anticonvulsants in complex therapy of RA and OAk.Patients and m...

Full description

Bibliographic Details
Main Authors:	E. S. Filatova, A. M. Lila
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2021-04-01
Series:	Современная ревматология
Subjects:	ревматоидный артрит остеоартрит коленных суставов анкилозирующий спондилит центральная сенситизация невропатическая боль
Online Access:	https://mrj.ima-press.net/mrj/article/view/1121

Similar Items

A very early clinical response to treatment with the Janus kinase inhibitor tofacitinib in patients with active rheumatoid arthritis: the dynamics of pain and central sensitization elements
by: A. E. Karateev, et al.
Published: (2020-05-01)

Chronic back pain from rheumatologist point of view
by: Yu. A. Olyunin, et al.
Published: (2022-10-01)

Fibromyalgia in rheumatoid arthritis: features of pain syndrome, impact on disease activity and quality of life of patients
by: N. A. Melikova, et al.
Published: (2022-02-01)

Assessment of pain in rheumatoid arthritis. Practical significance
by: Yu. A. Olyunin
Published: (2019-03-01)

Etoricoxib for generalized osteoarthritis. Case report
by: I. S. Dydykina, et al.
Published: (2021-02-01)

Results of an open multicenter non-interventional study of clinical efficacy and tolerability of etoricoxib in osteoarthritis and nonspecific back pain with additional evaluation of the effect of the drug on the «central» manifestations of pain
by: A. E. Karateev, et al.
Published: (2022-05-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

Rheumatic pain management: molecular aspects
by: E. V. Chetina, et al.
Published: (2020-03-01)

Features of geriatric status in elderly patients with osteoarthritis combined with neuropathic pain: data from the Russian epidemiological study EVKALIPT
by: A. V. Naumov, et al.
Published: (2022-06-01)

Golimumab for Treating Chronic Inflammatory Joint Diseases in the Adult Population: Clinical Efficacy and Tolerability
by: Natal’ya N. Chichasova
Published: (2019-01-01)

ETHORICOXIB IN THE TREATMENT OF RHEUMATIC DISEASES
by: Yu A Olyunin, et al.
Published: (2010-03-01)

Osteophytes in the Joints of Patients with Ankylosing Spondylitis: Manifestation of Osteoarthritis or Underlying Disease?
by: K. D. Dorogoykina, et al.
Published: (2020-05-01)

Chronic musculoskeletal pain. Leading symptom or comorbid pathology?
by: Yu. A. Olyunin
Published: (2022-06-01)

ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
by: A E Karateev
Published: (2009-06-01)

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study
by: L. I. Alekseeva, et al.
Published: (2021-02-01)

Assessing the status of patients with rheumatoid arthritis: modern tendencies
by: A. M. Lila, et al.
Published: (2020-05-01)

Combination of ankylosing spondylitis and rheumatoid arthritis: clinical observations and literature review
by: A. A. Godzenko, et al.
Published: (2021-08-01)

Role of ultrasonic examination in assessment of the knee-joint state in patients with juvenile idiopathic arthritis
by: V. O. Roschina, et al.
Published: (2012-10-01)

FAKTORY PROGRESSIROVANIYa OSTEOARTROZA KOLENNYKh SUSTAVOV (5-letnee prospektivnoeNABLYuDENIE)
by: N G KAShEVAROVA, et al.
Published: (2013-12-01)

CONSERVATIVE ORTHOPEDIC TREATMENT OF RHEUMATIC DISEASES: RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, OSTEOARTHROSIS, SOFT TISSUE DISEASES (PART II)
by: V P Pavlov
Published: (2009-06-01)

Comparative study of the efficacy and safety of Chondroguard® during its combined (intra-articular and intramuscular) and intramuscular injection in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2018-06-01)

New etanercept biosimilar — expanding treatment options for immune-mediated inflammatory rheumatic diseases
by: A. E. Karateev, et al.
Published: (2022-12-01)

Analysis of the factors determining the development of postoperative pain in patients after knee and hip replacement surgery
by: K. A. Glemba, et al.
Published: (2021-12-01)

Synovitis in osteoarthritis: the current state of the problem
by: I. S. Dydykina, et al.
Published: (2021-04-01)

Back pain and functional status in patients with ankylosing spondylitis during pregnancy
by: O. A. Krichevskaya, et al.
Published: (2019-10-01)

Back pain and assessment of ankylosing spondylitis activity during gestation: symptoms reflecting exacerbation of the disease and pregnancy
by: O. A. Krichevskaya, et al.
Published: (2022-10-01)

Analgesics in rheumatic diseases – a necessary component of therapy aimed at improving the quality of life
by: A. E. Karateev
Published: (2022-10-01)

Efficacy of Chondroitin Sulfate in Patients with Knee and Hip Osteoarthritis
by: E. P. Sharapova, et al.
Published: (2021-08-01)

Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis
by: Aleksandr Viktorovich Smirnov
Published: (2013-06-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
by: Yu. V. Muravyev, et al.
Published: (2020-05-01)

Diagnosis of spondyloarthritis: should we need new criteria?
by: I. Z. Gaidukova, et al.
Published: (2015-03-01)

Pain is a major component of quality of life in patients with ankylosing spondylitis and the possibilities of its relief
by: Oksana Anatolyevna Pirogova, et al.
Published: (2013-10-01)

Current views of the development of pain syndrome mechanisms in patients with osteoarthrosis. Rational pharmacotherapy
by: E. V. Igolkina
Published: (2014-09-01)

«I am getting better» and «I feel good»: searching for an objective criterion for a clinical response to analgesic therapy for rheumatic diseases
by: A. E. Karateev, et al.
Published: (2020-05-01)

THE RHEUMATOID HAND (Part II)
by: Yu A Olyunin, et al.
Published: (2010-03-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

Practical course on neuropathic pain for neurologist
by: A. P. Rachin, et al.
Published: (2015-12-01)

Extraskeletal manifestations and the indicators of inflammatory activity and severity in ankylosing spondylitis
by: A. A. Godzenko, et al.
Published: (2018-04-01)

Changing the concept of spondyloarthritis: Characteristics of teaching when changing the paradigm in a particular area of medical knowledge
by: I. Z. Gaydukova, et al.
Published: (2017-04-01)

PAIN IN RHEUMATOID ARTHRITIS: SPECIFIC FEATURES OF ITS DEVELOPMENT AND METHODS OF CORRECTION
by: Yuri Aleksandrovich Olyunin
Published: (2010-06-01)